Compare Hims and Hers Health Inc (HIMS) vs Medline Inc. Class A Common Stock (MDLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Medline Inc. Class A Common Stock — how do they compare? Hims and Hers Health Inc trades at $28.41 (market cap $6.55B), while Medline Inc. Class A Common Stock trades at $35.74 (market cap $31.36B). The key difference: Medline Inc. Class A Common Stock is far larger — about 4.8× Hims and Hers Health Inc's market cap, and Hims and Hers Health Inc is more actively traded (14,842,814 versus 10,191,251). Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Medline Inc. Class A Common Stock for 0 Days on average.
| HIMS | MDLN | |
|---|---|---|
Market Cap | $6.55B | $31.36B |
Volume | 14,842,814 | 10,191,251 |
Sector | Health | Health |
52-Week High | $62.76 | $49.99 |
52-Week Low | $14.52 | $31.64 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $7.25B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Medline Inc. Class A Common Stock
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →
